Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by Micr1on Jun 29, 2010 8:09pm
544 Views
Post# 17232819

RE: RE: HSBC Biotech holdings increasing?

RE: RE: HSBC Biotech holdings increasing?PLEASE someone explain to me why do you think HSBC is invested in SSS?....When we look at level 2, it's the institution's client who's actually buying NOT the institution itself, non!?!?!?!  I read posts stating "HSBC BUYING....ACCUMULATING BIG...WOWOW!!"  Unless someone can point me to where I hve to look to confirm it's truely the institutions, then please stop making such misleading statements, it's just your credebility that gets hit.

P.S.: this is not specifically directed to easymoney but to all who post this kind of stuff.  Stop posting or back it up please, and not with level 2 por favor!


Micrt1
Bullboard Posts